IL1B and dermatitis: Concerning the mode of action of icIL-1Ra1 in the skin, extracellular icIL-1Ra1 released by keratinocytes has been proposed to counter-regulate skin inflammation provoked by keratinocyte-derived IL-1α and/or by IL-1β, the latter mainly produced by infiltrating myeloid cells (94, 102, 111).